Abstract
Perspective
Key words
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The Journal of PainReferences
- Opioid controls: Regulate to educate.Pain Med. 2010; 11: 480-481
- Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000.Pain. 2004; 109: 514-519
Centers for Disease Control and Prevention: Unintentional Drug Poisoning in the United States, 2010
Centers for Disease Control and Prevention: CDC health disparities and inequalities report – United States, 2011
- Research gaps on use of opioids for chronic noncancer pain: Findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline.J Pain. 2009; 10: 147-159
- Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.J Pain. 2009; 10: 113-130
- Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States.Pharmacoepidemiol Drug Saf. 2007; 16: 827-840
- Prescription for Peril: How Insurance Fraud Finances Theft and Abuse of Addictive Prescription Drugs.Coalition Against Insurance Fraud, Washington, D.C.2007
Congressional Budget Office: Geographic Variation in Health Care Spending, 2008
- Geographic variation in the prescription of schedule II opioid analgesics among outpatients in the United States.Health Serv Res. 2006; 41: 837-855
- Correction to ‘‘Geographic Variation in the Prescription of Schedule II Opioid Analgesics among Outpatients in the United States’’.Health Serv Res. 2006; 41: 856-859
- Addressing the intersecting problems of opioid misuse and chronic pain treatment.Exp Clin Psychopharmacol. 2008; 16: 417-428
- What is too much variation? The null hypothesis in small-area analysis.Health Serv Res. 1990; 24: 741-771
Federation of State Medical Boards of the United States I: Model guidelines for the use of controlled substances for the treatment of pain. Euless, Texas, 1998
Federation of State Medical Boards of the United States I: Model policy for the use of controlled substances for the treatment of pain. Euless, Texas, 2004
- The implications of regional variations in Medicare spending. Part 1: The content, quality, and accessibility of care.Ann Intern Med. 2003; 138: 273-287
- The implications of regional variations in Medicare spending. Part 2: Health outcomes and satisfaction with care.Ann Intern Med. 2003; 138: 288-298
- Regulating opioid prescribing through prescription monitoring programs: Balancing drug diversion and treatment of pain.Pain Med. 2004; 5: 309-324
- Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research.The National Academies Press, Washington, DC,2011
- Trends in medical use and abuse of opioid analgesics.JAMA. 2000; 283: 1710-1714
- Pain management, controlled substances, and state medical board policy: A decade of change.J Pain Symptom Manage. 2002; 23: 138-147
- Pain knowledge and attitudes of healthcare providers: Practice characteristic differences.Clin J Pain. 1997; 13: 237-243
- Patterns and trends in opioid use among individuals with back pain in the United States.Spine (Phila Pa 1976). 2004; 29 (discussion 91): 884-890
- Time to take stock: A meta-analysis and systematic review of analgesic treatment disparities for pain in the United States.Pain Med. 2012; 13: 150-174
Office of National Drug Control Policy: Epidemic: Responding to America’s Prescription Drug Abuse Crisis. Office of National Drug Control Policy, Washington, DC, 2011
- Opioid prescriptions by U.S. primary care physicians from 1992 to 2001.J Pain. 2006; 7: 225-235
- Opioid analgesics and rates of fatal drug poisoning in the United States.Am J Prev Med. 2006; 31: 506-511
- Increasing deaths from opioid analgesics in the United States.Pharmacoepidemiol Drug Saf. 2006; 15: 618-627
- Vital Signs: Overdoses of prescription opioid pain relievers–United States, 1999-2008.MMWR Morb Mortal Wkly Rep. 2011; 60: 1-6
- Opioids and the management of chronic severe pain in the elderly: Consensus statement of an international expert panel with focus on the six clinically most often used World Health Organization step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008; 8: 287-313
- Integrating nine prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug abuse in the United States in 2007.Pharmacoepidemiol Drug Saf. 2009; 18: 778-790
- Detecting signals of opioid analgesic abuse: Application of a spatial mixed effect poisson regression model using data from a network of poison control centers.Pharmacoepidemiol Drug Saf. 2008; 17: 1050-1059
Strakowski SM, Weiss RD, Roy-Byrne PP, Compton WM: Tackling prescription drug abuse with formulary restriction? In Medscape Psychiatry 2012
Substance Abuse and Mental Health Services Administration: The NSDUH Report: Trends in Nonmedical Use of Prescription Pain Relievers: 2002 to 2007. Rockville, MD, 2009
Substance Abuse and Mental Health Services Administration: Treatment Episode Data Set (TEDS) Highlights - - 2007 National Admissions to Substance Abuse Treatment Services. OAS Series #S-45, HHS Publication No. (SMA) 09–4360 ed. Office of Applied Studies, Rockville, MD, 2009
- Drug Abuse Warning Network, 2009: National Estimates of Drug-Related Emergency Department Visits.Substance Abuse and Mental Health Services Administration, Rockville, MD2011
- Opioids in the management of chronic non-cancer pain: An update of American Society of the Interventional Pain Physicians’ (ASIPP) Guidelines.Pain Physician. 2008; 11: S5-S62
- Physicians’ attitudes and practices regarding the long-term prescribing of opioids for non-cancer pain.Pain. 1994; 59: 201-208
U.S. Dept. of Health and Human Services: Area Resource File (ARF) Access System 2008. (Health Resources and Services Administration Bureau of Health Professions, Ed.). Rockville, MD, 2008
U.S. Dept. of Justice: Automation of Reports and Consolidated Orders System (ARCOS), Retail Drug Summary. Available at: http://www.deadiversion.usdoj.gov/arcos. Accessed December 2011
- The promotion and marketing of oxycontin: Commercial triumph, public health tragedy.Am J Public Health. 2009; 99: 221-227
- Chronic pain reconsidered.Pain. 2008; 138: 267-276
- Geographic variation in opioid prescribing for acute, work-related, low back pain and associated factors: A multilevel analysis.Am J Ind Med. 2009; 52: 162-171
- United States’ trends and regional variations in lumbar spine surgery: 1992-2003.Spine (Phila Pa 1976). 2006; 31: 2707-2714
- Do drug regulations affect medical practice?.J Pain Symptom Manage. 1992; 7: 257-258
- Time to tackle unwarranted variations in practice.BMJ. 2011; 342
- Geography and the debate over Medicare reform.Health Aff (Millwood). 2002; : W96-114
- Opioid analgesics for pain control: Wisconsin physicians’ knowledge, beliefs, attitudes, and prescribing practices.Pain Med. 2010; 11: 425-434
- College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: Position statement.Drug Alcohol Depend. 2003; 69: 215-232
- Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002.Med Care. 2006; 44: 1005-1010
- Geographic variation in Medicare drug spending.N Engl J Med. 2010; 363: 405-409
- Geographic variation in the quality of prescribing.N Engl J Med. 2010; 363: 1985-1988
Article info
Publication history
Footnotes
This study was supported by grant RC2 DA028920 awarded by the Office of the Director, National Institutes of Health, National Institute on Drug Abuse. Prescription LRx Data, 2008 was obtained by Abt Associates under license from IMS Health Incorporated; all rights reserved. County location of prescribers’ offices obtained from Physician Professional Data, 2008, American Medical Association; all rights reserved. None of the authors has any institutional or personal conflict of interest. Authors had full access to all of the data in the study and are responsible for the integrity of the data and the accuracy of the analyses. Abt Associates' Institutional Review Board approved this study. The statements, findings, conclusions, views, and opinions contained and expressed herein are not necessarily those of the National Institutes of Health, the National Institute on Drug Abuse, Abt Associates Inc., or IMS Health Incorporated or any of its affiliated or subsidiary entities.
